Discovery of new molecular subtypes in oesophageal adenocarcinoma.

A large number of patients suffering from oesophageal adenocarcinomas do not respond to conventional chemotherapy; therefore, it is necessary to identify new predictive biomarkers and patient signatures to improve patient outcomes and therapy selections. We analysed 87 formalin-fixed and paraffin-em...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daniela Berg, Claudia Wolff, Rupert Langer, Tibor Schuster, Marcus Feith, Julia Slotta-Huspenina, Katharina Malinowsky, Karl-Friedrich Becker
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/999b038ba7a44b0f988a417d09262fb7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!